We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy

By HospiMedica International staff writers
Posted on 03 Feb 2026

Excessive antibiotic use has accelerated the emergence of bacterial resistance to standard therapies, fueling a global health crisis projected to cause more than 10 million deaths annually by 2050. More...

Among the most concerning pathogens, multidrug-resistant Pseudomonas aeruginosa accounts for approximately 20% of hospital-acquired pneumonia cases and is associated with severe disease and increased mortality. To address this challenge, investigators now report that high-dose inhaled nitric oxide demonstrates antimicrobial activity in preclinical models and was safe and feasible in early human exposure studies.

A research team at Mass General Brigham (Boston, MA, USA) investigated whether brief exposures to high concentrations of inhaled nitric oxide (iNO), a therapeutic gas with established use in critical care, could exert direct antipseudomonal effects while remaining tolerable for patients. In vitro experiments first showed dose-dependent killing of Pseudomonas aeruginosa using nitric oxide–releasing compounds. The team then tested the approach in a pig model of experimental pneumonia, where treatment with high-dose iNO at 300 parts per million significantly reduced bacterial burden compared with untreated controls and was associated with improved oxygenation and other indicators of lung infection.

Feasibility and safety were then assessed in humans through repeated exposure to high-dose inhaled nitric oxide. The investigators evaluated 10 healthy volunteers and two critically ill patients with multidrug-resistant bacterial infections, finding that treatment was well tolerated with no serious safety concerns. A retrospective analysis of patients who received high-dose inhaled nitric oxide in clinical settings, primarily during the COVID-19 pandemic, further supported its safety profile. The findings were published in Science Translational Medicine.

“These results suggest a promising strategy that could complement existing treatments. However, rigorous clinical trials are essential before this approach can be considered for routine clinical use,” said senior author Lorenzo Berra, MD, Mass General Brigham Department of Anesthesia, Critical Care and Pain Medicine: 

Related Links
Mass General Brigham


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.